Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Virol. Jun 25, 2024; 13(2): 91286
Published online Jun 25, 2024. doi: 10.5501/wjv.v13.i2.91286
Combined prevention and treatment measures are essential to control nosocomial infections during the COVID-19 pandemic
Jing-Wen Liu, Yue-Yue Li, Ming-Ke Wang, Ji-Shun Yang
Jing-Wen Liu, Yue-Yue Li, Ji-Shun Yang, Medical Care Center, Naval Medical Center of PLA, Naval Medical University, Shanghai 200052, China
Jing-Wen Liu, Yue-Yue Li, School of Pharmacy, Bengbu Medical College, Bengbu 233000, Anhui Province, China
Ming-Ke Wang, Department of Disease Control and Prevention, Naval Medical Center of PLA, Naval Medical University, Shanghai 200052, China
Co-corresponding authors: Ming-Ke Wang and Ji-Shun Yang.
Author contributions: Wang MK and Yang JS conceptualized, designed, and revised the manuscript; Liu JW drafted the manuscript; Li YY collected the literature. All authors have read and approved the final manuscript. Both Wang MK and Yang JS have conceptualized, proposed, designed, and supervised the whole process of the article, and played important and indispensable roles in the manuscript preparation and revision as the co-corresponding authors. Wang MK applied for and obtained the funds for this research project. Wang MK conceptualized, designed, revised and supervised the whole process of the project. Yang JS was instrumental, conceptualized, and revised the manuscript. This collaboration between Wang MK and Yang JS is crucial for the publication of this manuscript and other manuscripts still in preparation.
Supported by Scientific Research Foundation of Shanghai Municipal Health Commission of Changning District, No. 20234Y038.
Conflict-of-interest statement: All authors have no conflict of interest related to the manuscript.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ming-Ke Wang, MD, PhD, Associate Chief Physician, Department of Disease Control and Prevention, Naval Medical Center of PLA, Naval Medical University, No. 338 Huaihai West Road, Changning District, Shanghai 200052, China. wmke021@163.com
Received: December 26, 2023
Revised: March 20, 2024
Accepted: April 10, 2024
Published online: June 25, 2024
Processing time: 180 Days and 22.2 Hours
Core Tip

Core Tip: During the coronavirus disease 2019 (COVID-19) pandemic, nosocomial infections severely challenged healthcare professionals worldwide. Mitigating intra-hospital diseases remains a crucial task for healthcare practitioners. This study concentrated on pivotal strategies for preventing and controlling COVID-19 infections within medical facilities. It advocated viral infection prevention through vaccination, disinfection, and the training of heathcare personnel. Simultaneously, it explored therapeutic strategies involving cellular inflammatory factors and certain new medications tailored for COVID-19 patients. These methods could prevent and control intra-hospital infections swiftly and effectively during the COVID-19 outbreak.